NCT01187485 - A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer | Biotech Hunter

Enrollment

15

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

February 29, 2008

Study Completion Date

February 28, 2009

Conditions

Prostate Cancer

Interventions

DRUG

Androderm® 2.5mg

Subjects will be asked to replace the study drug patch every 24 hours at night following the written and verbal instructions you will receive. The study drug patch should be placed over a small amount of a steroid cream on the skin to reduce irritation.

DRUG

Androderm® 5.0mg

Subjects will be asked to replace the study drug patch every 24 hours at night following the written and verbal instructions you will receive. The study drug patch should be placed over a small amount of a steroid cream on the skin to reduce irritation.

DRUG

Androderm® 7.5mg

Subjects will be asked to replace the study drug patch every 24 hours at night following the written and verbal instructions you will receive. The study drug patch should be placed over a small amount of a steroid cream on the skin to reduce irritation.

Trial Locations (1)

60637

University of Chicago, Chicago